SSSarah A. Sydlowski

Sarah A. Sydlowski

*This is an algorithmically generated author record based on publicly available information.

Sarah A. Sydlowski has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Proposed Development of a New Staging System for Hearing Loss: Countermeasure 2 of the Hearing Health Collaborative

    by Matthew L. Carlson, Teresa A. Zwolan, Matthew L. Bush, Maura K. Cosetti, Camille C. Dunn, Samuel P. Gubbels, Richard K. Gurgel, Ardeshir Z. Hashmi, Meredith A. Holcomb, Jacob B. Hunter, et al.

    Hearing loss is a highly prevalent disease state affecting almost 1 in 5 individuals globally. Growing research shows that untreated or undertreated hearing loss carries significant long-term sequelae, including increased risk of social isolation, depression, and cognitive decline, among other ramifications. Limited awareness and common misperceptions among the general US adult population and primary care providers contribute to low rates of referral to hearing specialty clinics and underutilization of hearing aids, cochlear implants, and other rehabilitative devices. Comprised of diverse membership, the Hearing Health Collaborative (HHC) was formed in May 2021 to identify and overcome challenges impacting good health care practices and public policy on hearing care in connection with healthy aging. This editorial documents a recent outcome of the HHC derived from a structured A3 process. Specifically, initiative 2, a proposal to develop a simple, clinically anchored staging system primarily for use by frontline providers and patients, is presented. Unlike other common disorders that harbor long-term health sequelae, a corresponding pragmatic clinical staging system—leveraging precedent disease staging convention, based on clinically meaningful outcomes and prognosis for acquired hearing loss—does not exist. The development of this staging system will potentially allow for improved communication across providers and patients, facilitate referral pathways, and ultimately enable patient access to timely and appropriate care.

  • Teamwork Is Not Just Dreamwork: An Intentional, Evidence-Based Approach to Building and Maintaining an Effective Team

    by Sarah Sydlowski, Marc Bassim

    Contemporary healthcare delivery requires the optimal application of cooperative, collaborative teamwork in order to address the complex needs of patients. Failure to communicate and work effectively as teams has been cited as a leading driver for poorer clinical outcomes and patient satisfaction. Yet, hierarchical models persist, including within hearing implant programs, where interdisciplinary coordination is imperative. Other industries and healthcare specialties have successfully analyzed and adopted best practices for the development of effective teams. These practices include identifying ideal team members, optimizing team dynamics, and nurturing a team-oriented culture. This article highlights the key considerations for creating and maintaining effective teams in hearing implant programs.


  • Open Access

    Perceptions Surrounding Cochlear Implants Among At-Risk and Qualifying Older Adults in the United States

    by Matthew L. Carlson, Christine M. Lohse, John P. Marinelli, Sarah A. Sydlowski, Hearing Health Collaborative

    Objective: Limited evidence to date has examined public perceptions of cochlear implants among adult hearing aid users with moderate to profound hearing loss. The current work was conceived with the chief objective of characterizing the perceptions surrounding cochlear implants among the prospective candidate pool. Study design: National cross-sectional survey study. Setting: United States. Patients: Adults between 50 and 80 years of age with self-reported moderate to moderately severe (n = 200) or moderately severe to profound (n = 200) hearing loss currently using hearing aids. Results: The overall survey response rate was 12%. Median age at time of survey for the 400 respondents was 66 years (interquartile range, 60–71 yr) and included 215 (54%) men. In total, 26% did not think of hearing loss as a medical condition, and another 23% were unsure. Overall, 63% of respondents had heard of cochlear implants, but only 2% indicated they were very familiar with them. Despite 52% of respondents reporting “very positive” or “somewhat positive” feelings about cochlear implants, only 9% indicated they were “very likely” to get a cochlear implant in the future, including 7% of those with estimated moderately severe to profound hearing loss at time of survey. Conclusions: Even among people with presumed qualifying levels of hearing loss, there exists a widespread lack of familiarity with cochlear implantation as a viable treatment option. This limited awareness seems influenced by a generally poor appreciation for hearing loss as a chronic disease state that warrants treatment. However, among those familiar with cochlear implants, they are generally viewed favorably.


  • (Even Off-Label) Cochlear Implantation in Single-Sided Deafness and Asymmetric Hearing Loss Results in Measurable Objective and Subjective Benefit

    by Sarah A. Sydlowski, Nathan Farrokhian, Marisa Carrozza, Carmen Jamis, Erika Woodson

    Objective: To quantify objective and subjective outcomes in cochlear implant (CI) recipients with asymmetric hearing loss, including single-sided deafness (SSD) whose candidacy was determined on an ear-specific basis when word recognition was 50% or less. Study Design: Retrospective case review. Setting: Tertiary referral center. Background: The effectiveness of CI in cases of SSD and asymmetric hearing loss (AHL) has been described in terms of tinnitus suppression, improved speech recognition in quiet and noise, enhanced localization ability, and improved quality of life. However, CI is not yet routinely offered as a top option or standard of care for these individuals. Recent Food and Drug Administration (FDA) labeling limits aided word recognition in the ear to be implanted to only 5% in cases of AHL/SSD, which is significantly poorer than 40 to 50%, which is often referenced in cases of bilateral hearing loss. Anecdotal experience suggests that patients with much better preoperative word recognition than 5% can benefit from CI. Methods: We conducted a retrospective chart review of all adult CI candidates, with one ear exhibiting consonant-nucleus-consonant (CNC) word recognition scores at least 50% and one ear not meeting CI candidacy (i.e., CNC word recognition >50%). Outcome variables of interest included word and sentence recognition and subjective handicap questionnaires (hearing, tinnitus, dizziness) and the Speech Spatial Qualities questionnaire. Results: Statistically and clinically significant improvement in speech understanding (word, sentence, sentence in noise) was noted for both the SSD and AHL groups in the implanted ear. There were statistically and clinically significant subjective improvements noted for both groups on the Hearing Handicap Inventory, the Tinnitus Handicap Inventory, and the Speech Spatial Qualities questionnaire by 1 month after activation. There were no significant differences between the AHL and SSD groups on either objective or subjective measures of the implanted ear. Individual word understanding improved for the majority of recipients across both groups and is not dependent on meeting the FDA criteria of less than 5%. Conclusions: Cochlear implantation is a viable option with measurable objective and perceived benefits for recipients with preoperative aided CNC word scores exceeding current FDA labeling. There is no significant difference between the AHL and SSD groups, suggesting that candidacy and outcome expectations should be set based on the ear to be implanted alone, without regard for the ability of the better hearing ear.


  • Open Access

    Hearing Health Perceptions and Literacy Among Primary Healthcare Providers in the United States: A National Cross-Sectional Survey

    by Sarah A. Sydlowski, John P. Marinelli, Christine M. Lohse, Matthew L. Carlson, Hearing Health Collaborative

    Objective: To characterize current awareness, perceptions, and literacy surrounding hearing loss among United States primary healthcare professionals. Study design: National cross-sectional survey study. Setting: United States. Participants: Four hundred six healthcare professionals. Results: Survey respondents included 205 primary care physicians and 201 nurse practitioners or physician assistants. When compared with 10 other common health conditions, only 1% of respondents ranked hearing loss as a “most important” health condition to manage. Less than half of providers reported recommending hearing testing for their patients at least once per year, whereas evaluation of blood pressure, total cholesterol, body mass index, and blood glucose levels are recommended at least annually by more than 80% of providers. Although 95% of respondents indicated that it is somewhat important or very important for patients to know the standard definition for normal hearing, only 57% of surveyed providers know of a standard definition themselves, and only 28% reported familiarity with the concept of “20/20 hearing.” Conversely, more than 80% of respondents know the “normal” metric for blood pressure, total cholesterol, body mass index, blood glucose, and vision. Most respondents realize that hearing is important to overall health and hearing loss can impact personal safety, lead to social isolation, and negatively impact quality of life. Fifty-four percent also acknowledged a link between hearing loss and depression, but a majority were not very aware of the relationship of hearing loss to risk of falling and dementia, reduced income and job opportunities, and type 2 diabetes. Importantly, only 40% of providers believe hearing loss is treatable, and only 17% believe it is preventable. Conclusion: Despite widespread literacy of what constitutes normal blood pressure, total cholesterol, body mass index, blood glucose, and vision metrics, healthcare providers exhibit a poor understanding of normal hearing levels. Few providers prioritize hearing health or regularly recommend for annual hearing evaluation. Most providers believe that options for people with hearing loss are limited, which may have important implications for prioritizing discussion of hearing loss with patients.


  • Open Access

    Barriers to Cochlear Implant Access: Acknowledging the Challenges, Changing the Future

    by Sarah Sydlowski

    Since the earliest recipients received their devices more than 40 years ago, cochlear implantation has continued to evolve, benefitting more individuals with greater diversity of hearing loss. Originally introduced for those with bilateral profound cochlear hearing loss, cochlear implants (CIs) were considered to be the last resort when hearing aids could no longer provide any benefit. Today this perspective is considered woefully outdated. Successful recipients include those with single-sided deafness, asymmetric hearing loss, residual hearing in the implanted ear up to and including normal thresholds through 1,000 Hz, sudden loss, long duration progressive loss, congenital loss implanted by 9 months of age, auditory neuropathy spectrum disorder (ANSD), and more. Candidacy determination is shifting from use of sentences in quiet in the best-aided condition to ear-specific word recognition scores. Electric-acoustic stimulation in the same ear is possible. Notably, implantation as soon as possible once benefit is determined to be likely is encouraged and has been shown to result in better outcomes. Yet, despite the exciting advancements that should be improving access to cochlear implantation and exponentially increasing utilization, numerous barriers persist. Misconceptions of contemporary candidacy, lack of comfort recommending CI, inequities of health-related socioeconomic resources, outdated device labeling, restrictive insurance coverage policies, lack of clarity regarding the link to cognitive health, and lack of awareness by the public and referring providers have combined to prevent more than an estimated 1 million patients who could benefit from CI from receiving this care.[1] Recognizing that knowledge is power, this issue of Seminars in Hearing explores these barriers to cochlear implantation and seeks to empower clinicians to successfully move their candidate patients past those barriers to enjoy better hearing and communication through cochlear implantation. This edition brings together a diverse and accomplished group of audiologists, neurotologists, and public health specialists to outline the inherent problems with existing barriers, to explore the opportunities that will arise from recognizing and embracing best practices, and to deliver a case for change to increase utilization of this proven, life-changing technology. The issue opens with an analysis and quantification of the current problem. Ashley Nassiri, MD, MBA, and colleagues map the patient experience as a way to uncover obstacles that CI candidates and recipients face at nearly every step of the process. Marissa Schuh, MPH, and Matthew Bush, MD, PhD, MBA, explore the disparities in cochlear implantation through the social determinants of health. Consideration is given to how these factors can influence equity in CI and how to incorporate this information in the evaluation and management of patients receiving CIs. The focus then shifts more specifically to the adult population. Terry Zwolan, PhD, and Greg Basura, MD, discuss how the rate of improvement in adult CI outcomes has outpaced expansion of candidacy requirements of FDA labeling, Medicare, and private insurers in the United States, preventing many qualified candidates from financial coverage of CI technology. Eric Babajanian, MD; Neil Patel, MD; and Richard Gurgel, MD examine the relationship between cochlear implantation and cognition and quality of life in older adults, as well as how frailty affects outcomes for older patients with CIs. Sarah Mowry, MD, and colleagues dispel common myths and misconceptions related to the risks associated with CI surgery that may deter providers from recommending and patients from pursuing cochlear implantation. Finally, my colleagues and I describe the importance of hearing aid verification using aided speech recognition materials during hearing aid fitting and follow-up to confirm optimal functional of hearing aid benefit, both as routine practice and as an essential component of the CI candidacy evaluation. Last but not least, challenges unique to the youngest CI candidates are discussed as Lisa Park, AuD, and colleagues highlight the limitations of FDA criteria and clinical practice for pediatric patients compared with adults as a barrier to pediatric implantation. Karen Gordon, PhD, and colleagues make the case for the importance of access to bilateral hearing through CI in children. We hope that by compiling in one location many of the key factors of under-utilization of CIs in the United States today, we have created an essential resource for empowering change for the industry, for our practices, and, most importantly, for the hundreds of thousands of patients who are struggling to achieve their best possible hearing and for whom cochlear implantation may be the answer. Article published online: 09 December 2021 © 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

  • Optimizing Care Delivery by Applying an Innovative Shared Medical Appointment Model for Determination of Cochlear Implant Candidacy

    by Sarah Sydlowski, Cara Donovan, Jordan McNair, Katie Hahn, Karen Petter, Tina Marks, Tom Haberkamp, Anh Nguyen-Huynh, James Podriznik, Erika Woodson

    Objective: To develop and implement an innovative group appointment with the potential to improve access to cochlear implantation (CI) while maintaining patient satisfaction and experience. Patients: Adult patients with advanced sensorineural hearing loss. Intervention(s): Implementation of novel shared medical appointment (SMA) model. Main Outcome Measure(s): Patient satisfaction with group visit; anecdotal description of provider efficiency and experience. Results: Survey data were collected from 166 adults who participated in a group CI candidacy appointment from September 2017 to February 2020 as part of a quality improvement initiative. Provider time is anecdotally optimized by accommodating more patients in a shorter timeframe while effectively triaging those candidates most likely to meet candidacy criteria for a full CI evaluation. Most importantly, patient feedback has been positive which suggests that patients find value in this novel format. Conclusions: The current climate of healthcare demands that providers maximize the efficacy and efficiency of patient care. Our large CI program has determined that using an SMA format as an entry point for CI candidacy evaluation offers many benefits. The group appointment improves patient throughput and also provides a positive patient experience. Group visits offer a viable solution for increasing patient access to CI while maintaining quality in a busy academic medical center setting.


  • Initial hearing preservation outcomes of cochlear implantation with a slim perimodiolar electrode array

    by Erika Woodson, Rebecca Chota Nelson, Molly Smeal, Thomas Haberkamp, Sarah Sydlowski

    To assess the slim modiolar array as a hearing preservation electrode. Retrospective chart review of adult, post-lingual CI recipients implanted with slim modiolar array Sept 2016 to July 2017 in a...


  • Auditory Profile in Superficial Siderosis of the Central Nervous System

    by Sarah A. Sydlowski, Michael Levy, Wendy D. Hanks, M. Diane Clark, R. Steven Ackley

    Objective To identify auditory pathology resulting from superficial siderosis of the central nervous system (SSCN), auditory site of lesion, and a clinical profile for differential diagnosis and development of recommendations. Study Design Prospective study. Setting Academic clinical center. Patients Ten participants with SSCN (the largest prospective evaluation of audiologic status reported to date). Intervention(s) Demographics, clinical characteristics and history, audiometric evaluation, and Tinnitus Handicap Inventory (THI). Main Outcome Measure(s) Type and degree of hearing loss, relationship to clinical course of SSCN, and expected results based on age and sex. Results Sensorineural hearing loss (SNHL) is the most common symptom in SSCN (100%). Tinnitus (100%), imbalance (80%), and gait disorder (80%) were also frequently reported. Hearing loss is typically bilateral, asymmetric, progressive, sloping, and exceeds expected hearing loss related to age and sex. Hearing loss may be cochlear and/or retrocochlear in origin. Decreased word recognition is possible, and traditional amplification may offer limited benefit. Conclusion We observed significant audiometric findings in all participants. SSCN variably and pathologically targets the auditory system without regard for duration of disorder. A long asymptomatic phase and lack of predictive relationship between duration and severity of hearing loss makes suspicion of SSCN based solely on audiometric battery difficult; however, asymmetric hearing loss exceeding expectations, particularly with history of head trauma or previous neurosurgical procedure, should raise a red flag and trigger further medical evaluation including MRI. Diagnosis of SSCN may alter expectations for audiologic prognosis and is a critical component for comprehensive management of SSCN patients.


  • Superficial Siderosis of the Central Nervous System

    by Sarah A. Sydlowski, Michael J. Cevette, Jon Shallop

    Objective: Superficial siderosis of the central nervous system (SSCN) results after chronic subarachnoid hemorrhage. Consequent demyelination, particularly of the cochleovestibular nerve and cerebellum, causes auditory-vestibular dysfunction. Predominant symptoms include progressive sensorineural hearing loss, imbalance, and ataxia. Despite characteristic auditory-vestibular involvement, SSCN is not well known among the hearing health community. Study Design: Clinical records of 49 patients diagnosed with SSCN were reviewed. Analysis included review of demographic, audiometric, and vestibular data of the largest sample to date and comparison to 31 audiovestibular case reports in the literature. Results: Hearing loss and disordered balance were reported by 92% and 67% of patients, respectively. Results suggest variable but substantial auditory-vestibular involvement related to SSCN. Hearing loss is typically progressive, sloping, and asymmetric and exceeds hearing loss expected based on age or sex. Decreased word recognition is possible and traditional amplification may fail to provide benefit. Conclusion: SSCN is a destructive disorder affecting the auditory-vestibular system. Although not a common diagnosis, SSCN may be more prevalent than clinicians realize. Site of lesion may be anywhere within the auditory-vestibular system from the inner ear to the cortex, although the cochleovestibular nerve and cerebellum are particularly vulnerable. The progressive retrocochlear nature of the disorder makes differential diagnosis difficult and development of effective treatment options challenging. It is essential that audiologists and otologists recognize this uncommon cause of sensorineural hearing loss and balance disorder and the implications for evaluation, treatment, and counseling.